TrialHaematologica2019

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.

Anna B Halpern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.